Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical, demographic, and pharmacological predictors of medication adherence to disease-modifying therapies in multiple sclerosis: a multidimensional analysis of merged survey and claims data.
Long-term visual outcomes and treatment-related prognostic variables in pediatric demyelinating optic neuritis: A 10-year retrospective cohort study.
Glucose-dependent spatial and temporal modulation of oligodendrocyte progenitor cell proliferation via ACLY-regulated histone acetylation.
Microglia and neuroinflammation: function, heterogeneity, and crosstalk.
Radiologists' recommendations following MRI for optic neuritis: influence of report wording and patient accessibility in a tertiary neuro-ophthalmology clinic.
From inflammation to neurodegeneration: an exploratory pilot study of a diagnostic framework for progression in MS.
Perioperative Predictors of Length of Stay and Readmission After Simple Cystectomy and Urinary Diversion in Nonambulatory Adults With Neurogenic Bladder.
Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia.
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Compromised blood-brain barrier in traumatic brain injury model of : A unique window to demonstrate restoration of behavioral, cellular, and neurochemical deficits by limonin.
Multi-tier signaling and chromatin remodeling coordinate microglia inflammatory states and activities associated with demyelination.
A multi-sequence MRI integration framework using SwinUNETR-v2 for multiple sclerosis lesion segmentation.
Raman and SERS Spectra of Human Myelin Basic Protein in Cerebrospinal Fluid.
Validation of rule-based detection methods for relapse in multiple sclerosis.
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal.
Insights From Quantitative Susceptibility Mapping: An Umbrella Review of Multiple Sclerosis.
Comorbidities and Outcomes in People With Functional Neurological Disorder.
Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis.
Comparative effects of dry needling on spasticity, balance, and cortical excitability in stroke and multiple sclerosis patients: A pilot study.
The Interplay of Neighborhood Deprivation, Race, and Multiple Sclerosis.
Therapeutic Plasma Exchange in Thailand: A 10-Year Retrospective Analysis.
Evidence-Based Cognitive Rehabilitation for Persons with Multiple Sclerosis: An Updated Systematic Review 2016 to 2024.
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.
No association of complex regional pain syndrome and other neurological disorders with human papillomavirus vaccination in a large-scale real-world database.
Neurology Wait Times After Primary Care or Emergency Department Visits Among the Commercially Insured Population in the United States: 2019-2023.
Pages
« first
‹ previous
…
950
951
952
953
954
955
956
957
958
…
next ›
last »